Postoperative Nausea and Vomiting and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Postoperative Nausea and Vomiting (PONV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Postoperative Nausea and Vomiting (PONV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Postoperative Nausea and Vomiting (PONV) Overall Market Size
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size: 2022 VS 2030
2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.2 Top Global Postoperative Nausea and Vomiting (PONV) Companies Ranked by Revenue
3.3 Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies
3.4 Top 3 and Top 5 Postoperative Nausea and Vomiting (PONV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.6.1 List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Postoperative Nausea and Vomiting (PONV) Market Size Markets, 2022 & 2030
4.1.2 Serotonin Antagonists
4.1.3 Steroids
4.1.4 Dopamine Antagonists
4.1.5 NK-1 Receptor Antagonists
4.1.6 Non-pharmacologic Treatment
4.1.7 Others
4.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
4.2.1 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2023
4.2.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2024-2030
4.2.3 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
5.2.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2023
5.2.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2024-2030
5.2.3 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2022 & 2030
6.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
6.2.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2023
6.2.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2024-2030
6.2.3 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.3.2 US Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.3.3 Canada Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.3.4 Mexico Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.4.2 Germany Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.3 France Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.4 U.K. Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.5 Italy Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.6 Russia Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.7 Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.8 Benelux Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.5.2 China Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.4 South Korea Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.5 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.6 India Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.6.2 Brazil Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.6.3 Argentina Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.7.2 Turkey Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7.3 Israel Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7.4 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7.5 UAE Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
7 Postoperative Nausea and Vomiting (PONV) Companies Profiles
7.1 Acacia Pharma
7.1.1 Acacia Pharma Company Summary
7.1.2 Acacia Pharma Business Overview
7.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.1.5 Acacia Pharma Key News & Latest Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Ani Pharmaceuticals
7.4.1 Ani Pharmaceuticals Company Summary
7.4.2 Ani Pharmaceuticals Business Overview
7.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.4.5 Ani Pharmaceuticals Key News & Latest Developments
7.5 Camurus
7.5.1 Camurus Company Summary
7.5.2 Camurus Business Overview
7.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.5.5 Camurus Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Helsinn Holding
7.7.1 Helsinn Holding Company Summary
7.7.2 Helsinn Holding Business Overview
7.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.7.5 Helsinn Holding Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Postoperative Nausea and Vomiting (PONV) Market Opportunities & Trends in Global Market
Table 2. Postoperative Nausea and Vomiting (PONV) Market Drivers in Global Market
Table 3. Postoperative Nausea and Vomiting (PONV) Market Restraints in Global Market
Table 4. Key Players of Postoperative Nausea and Vomiting (PONV) in Global Market
Table 5. Top Postoperative Nausea and Vomiting (PONV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
Table 9. List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Postoperative Nausea and Vomiting (PONV) Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2024-2030
Table 30. Acacia Pharma Company Summary
Table 31. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 32. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 33. Acacia Pharma Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Company Summary
Table 35. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 36. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann-La Roche Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 40. Novartis Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Ani Pharmaceuticals Company Summary
Table 43. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 44. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 45. Ani Pharmaceuticals Key News & Latest Developments
Table 46. Camurus Company Summary
Table 47. Camurus Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 48. Camurus Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 49. Camurus Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 52. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Helsinn Holding Company Summary
Table 55. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 56. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 57. Helsinn Holding Key News & Latest Developments
Table 58. Eisai Company Summary
Table 59. Eisai Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 60. Eisai Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 61. Eisai Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 64. Merck Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product Offerings
Table 68. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (US$, Mn) & (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
List of Figures
Figure 1. Postoperative Nausea and Vomiting (PONV) Segment by Type in 2022
Figure 2. Postoperative Nausea and Vomiting (PONV) Segment by Application in 2022
Figure 3. Global Postoperative Nausea and Vomiting (PONV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Postoperative Nausea and Vomiting (PONV) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
Figure 8. By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 9. By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 10. By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 12. By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 14. By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 15. By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 16. US Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 20. Germany Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 21. France Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 28. China Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 32. India Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 34. Brazil Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
Figure 37. Turkey Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Postoperative Nausea and Vomiting (PONV) Revenue, (US$, Mn), 2018-2030
Figure 41. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Camurus Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eisai Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
